“They’re plowing new ground [with the design of pharmacy benefits on exchanges]. There’s not a lot of strong guidance coming out of the feds or CMS on how the marketplace formularies are going to operate. It’s even unknown if plans are going to be able to modify or delete drugs from the marketplace formulary once it’s in. A normal insurance plan is able to modify the formulary during the plan year. We don’t know at this point if that’s going to happen.”
— Brian Bullock, CEO of The Burchfield Group, a pharmacy benefit consulting firm, told AIS’s Health Reform Week.
No comments:
Post a Comment